Volume 8, Issue 2 (2023)                   SJMR 2023, 8(2): 97-103 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Alamshah N, Jamaldini S H, Behjati F. Epigenetics Association of Non-coding RNAs with Preeclampsia. SJMR 2023; 8 (2) : 3
URL: http://saremjrm.com/article-1-296-en.html
1- Department of Molecular and Cellular Science, Faculty of Advanced Sciences Branch, Islamic Azad University, Tehran- Iran.
2- Department of Genetic, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
3- Sarem gynecology, Obstetrics and Infertility Research Center, Sarem Women's Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran. & Genetics Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Abstract:   (625 Views)
Preeclampsia (PE) is one of the severe complications of pregnancy that includes 3-5% of all pregnancies. This disorder in the functioning of the maternal organs or the placenta shows itself after the 20th week of pregnancy and is the cause of 10-15% of the deaths of pregnant mothers. Despite the progress achieved in the management of this disease in recent years, the main reason for the occurrence of this disease and the methods of early diagnosis and prevention have not been determined. Also, there are currently no clinically predictive biomarkers for preeclampsia. Recently, researchers have linked epigenetic factors with this disease. Non-coding RNAs, including miRNAs and long non-coding RNAs (lncRNAs), are epigenetic factors that play a role in the regulation of multiple cellular functions and are therefore widely investigated as potential biomarkers for various diseases. Altered expression of many lncRNAs and miRNAs in placenta is associated with pathophysiological processes occurring in preeclampsia. In this review article, various aspects of epigenetics on preeclampsia have been investigated.
Article number: 3
Full-Text [PDF 1074 kb]   (211 Downloads)    
Article Type: Systematical Review | Subject: Childbirth
Received: 2023/07/10 | Accepted: 2023/08/16 | Published: 2023/12/23

References
1. 1. Samaei SE, Vosoughi S, Taban E, Bagheri H1. Lyall F. RSC, Bulmer J.N. . Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: Relationship to clinical outcome. Hypertension. 2013:62:1046-54. [DOI:10.1161/HYPERTENSIONAHA.113.01892]
2. Sahai K, Saraswathy S, Yadav TP, Arora D, Krishnan M. Preeclampsia: Molecular events to biomarkers. Medical journal, Armed Forces India. 2017;73(2):167-74. [DOI:10.1016/j.mjafi.2016.09.001]
3. Mohammadi S, Pazhohideh Z, Abedi P, Maraqi E. Evaluation of Risk Factors in Preeclamptic Patients Admitted to 22 Bahman Hospital of Masjed Soleiman 2006-2010. The Iranian journal of obstetrics, gyncology and Infertility. September 2012; Vol. 15, No. 16, pp. 20-28. [DOI:10.1016/j.ogrm.2011.10.005]
4. Yang C, Baker PN, Granger JP, Davidge ST, Tong C. Long-Term Impacts of Preeclampsia on the Cardiovascular System of Mother and Offspring. Hypertension (Dallas, Tex : 1979). 2023;80(9):1821-33. [DOI:10.1161/HYPERTENSIONAHA.123.21061]
5. Wu S, Xie H, Su Y, Jia X, Mi Y, Jia Y, et al. The landscape of implantation and placentation: deciphering the function of dynamic RNA methylation at the maternal-fetal interface. Frontiers in endocrinology. 2023;14:1205408. [DOI:10.3389/fendo.2023.1205408]
6. von Wolff M, Germeyer A, Nawroth F. Fertility preservation for non-medical reasons: controversial, but increasingly common. Deutsches Arzteblatt international. 2015;112(3):27-32. [DOI:10.3238/arztebl.2015.0027]
7. Ye YZ, Zhou QJ, Xiao XR, Xiong Y, Li XT. [Latest Findings on Prediction and Prevention of Preeclampsia]. Sichuan da xue xue bao Yi xue ban = Journal of Sichuan University Medical science edition. 2022;53(6):1012-5.
8. Jafari A, Reiisi S, Parchami Sh, Ghatreh K, Amiri N, Miraj S . The Association of Serum Levels of Folic Acid and Homocysteine in Pregnant Women with Preeclampsia. The Iranian journal of obstetrics, gyncology and Infertility. June 2014; Vol. 17, No. 104, pp. 11-17.
9. Zhu L, Lv R, Kong L, Cheng H, Lan F, Li X. Genome-Wide Mapping of 5mC and 5hmC Identified Differentially Modified Genomic Regions in Late-Onset Severe Preeclampsia: A Pilot Study. PloS one. 2015;10(7):e0134119. [DOI:10.1371/journal.pone.0134119]
10. Vasconcelos S, Caniçais C, Chuva de Sousa Lopes SM, Marques CJ, Dória S. The role of DNA hydroxymethylation and TET enzymes in placental development and pregnancy outcome. Clinical epigenetics. 2023;15(1):66. [DOI:10.1186/s13148-023-01483-z]
11. Crosley EJ DC, Beristain AG, Christians JK. . IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells. Reprod Biol Endocrinol. 2014. [DOI:10.1186/1477-7827-12-123]
12. Jia Y, Li T, Huang X, Xu X, Zhou X, Jia L, et al. Dysregulated DNA Methyltransferase 3A Upregulates IGFBP5 to Suppress Trophoblast Cell Migration and Invasion in Preeclampsia. Hypertension (Dallas, Tex : 1979). 2017;69(2):356-66. [DOI:10.1161/HYPERTENSIONAHA.116.08483]
13. Nomura Y, John RM, Janssen AB, Davey C, Finik J, Buthmann J, et al. Neurodevelopmental consequences in offspring of mothers with preeclampsia during pregnancy: underlying biological mechanism via imprinting genes. Archives of gynecology and obstetrics. 2017;295(6):1319-29. [DOI:10.1007/s00404-017-4347-3]
14. Zhao Z, Kelle H, Moley T, Gronowski A, Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases, Clinical Biochemistry. 2013; 46(10): 953-960. [DOI:10.1016/j.clinbiochem.2013.01.026]
15. Wang T, Xiang Y, Zhou X, Zheng X, Zhang H, Zhang X, et al. Epigenome-wide association data implicate fetal/maternal adaptations contributing to clinical outcomes in preeclampsia. Epigenomics. 2019;11.(9):1003-19. [DOI:10.2217/epi-2019-0065]
16. Abdelazim SA, Shaker OG, Aly YAH, Senousy MA. Uncovering serum placental-related non-coding RNAs as possible biomarkers of preeclampsia risk, onset and severity revealed MALAT-1, miR-363 and miR-17. Scientific reports. 2022;12(1):1249. [DOI:10.1038/s41598-022-05119-9]
17. Redman CWG, Staff AC, Roberts JM. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways. Am J Obstet Gynecol. 2022;226(2s):S907-s27. [DOI:10.1016/j.ajog.2020.09.047]
18. Sun N, Qin S, Zhang L, Liu S. Roles of noncoding RNAs in preeclampsia. Reproductive biology and endocrinology : RB&E. 2021;19(1):100. [DOI:10.1186/s12958-021-00783-4]
19. Zhao Y, Zong F. Inhibiting USP14 ameliorates inflammatory responses in trophoblast cells by suppressing MAPK/NF-κB signaling. Immunity, inflammation and disease. 2021;9(3):1016-24. [DOI:10.1002/iid3.465]
20. Yang X, Meng T. Long Noncoding RNA in Preeclampsia: Transcriptional Noise or Innovative Indicators? BioMed research international. 2019;2019:5437621. [DOI:10.1155/2019/5437621]
21. Rahimi G, hoseini Asl S, Marghoub M, Seifolehi H, Amini F, Shahabzadegan S. LncRNA TERRA expression level and telomere length in placenta samples of healthy and preeclampsia women. The Iranian journal of obstetrics, gyncology and Infertility. May 2020; Vol. 32, No. 2, pp. 9-99.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | {Sarem Journal of Medical Research}

Designed & Developed by : Yektaweb